A patient undergoing chronic dialysis whose renal anemia was successfully corrected by treatment with cinacalcet

Clinical and Experimental Nephrology

Volumn 15, Issue 4, 2011, Pages 607-610

  Oshiro, Yoshiyuki ^a   Tanaka, Hisataka ^a   Okimoto, Niro ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Cinacalcet; Renal anemia; Secondary hyperparathyroidism

Indexed keywords

22 OXACALCITRIOL; ALKALINE PHOSPHATASE; CALCIUM; CINACALCET; HEMOGLOBIN; PARATHYROID HORMONE; RECOMBINANT ERYTHROPOIETIN;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ANEMIA; ARTICLE; CALCIUM BLOOD LEVEL; CASE REPORT; CHRONIC GLOMERULONEPHRITIS; DRUG DOSE REDUCTION; DRUG EFFICACY; FEMALE; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY FAILURE; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; RENAL ANEMIA; SECONDARY HYPERPARATHYROIDISM; TREATMENT DURATION;

ANEMIA; CALCIMIMETIC AGENTS; FEMALE; HUMANS; HYPERPARATHYROIDISM; HYPERPARATHYROIDISM, SECONDARY; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; NAPHTHALENES; PARATHYROID HORMONE; PARATHYROIDECTOMY; RENAL DIALYSIS;

EID: 80054725613     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-011-0433-1     Document Type: Article

References (17)

1. Barbour GL. Effect of parathyroidectomy on anemia in chronic renal failure. Arch Intern Med. 1979;139:889-91 (Pubitemid 10150843)
2. Goicoechea M, Gomez-Campdera F, Polo JR, Tejedor A, Ruiz MA, Vazquez I, et al. Secondary hyperparathyroidism as cause of resistance to treatment with erythropoietin: Effect of parathyroidectomy. Clin Nephrol. 1996;45:420-1 (Pubitemid 26187145)
3. Coen G, Calabria S, Bellinghieri G, Pecchini F, Conte F, Chiappini MG, et al. Parathyroidectomy in chronic renal failure: Short- and long-term results on parathyroid function, blood pressure and anemia. Nephron. 2001;88:149-55 (Pubitemid 32588869)
4. Goicoechea M, Vazquez MI, Ruiz MA, Gomez-Campdera F, Perez-Garcia R, Valderrabano F. Intravenous calcitriol improves anaemia and reduces the need for erythropoietin in haemodialysis patients. Nephron. 1998;78:23-7 (Pubitemid 28014455)
5. Nemeth EF, Steffey ME, Hammerland LG, Hung BC, Van Wagenen BC, DelMar EG, et al. Calcimimetics with potent and selective activity on the parathyroid calcium receptor. Proc Natl Acad Sci USA. 1998;95:4040-5 (Pubitemid 28173250)
6. Block GA, Martin KJ, de Francisco AL, Turner SA, Avram MM, Suranyi MG, et al. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med. 2004;350: 1516-25 (Pubitemid 38477776)
7. Rao DS, Shih MS, Mohini R. Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia. N Engl J Med. 1993;328:171-5 (Pubitemid 23021503)
8. Johnson DW, Pollock CA, Macdougall IC. Erythropoiesisstimulating agent hyporesponsiveness. Nephrology. 2007;12: 321-30
9. Kanbay M, Perazella MA, Kasapoglu B, Koroglu M, Covic A. Erythropoiesis stimulatory agent-resistant anemia in dialysis patients: Review of causes and management. Blood Purif. 2010;29:1-12
10. Urena P, Eckardt KU, Sarfati E, Zingraff J, Zins B, Roullet JB, et al. Serum erythropoietin and erythropoiesis in primary and secondary hyperparathyroidism: Effect of parathyroidectomy. Nephron. 1991;59:384-93
11. Fukagawa M, Yumita S, Akizawa T, Uchida E, Tsukamoto Y, Iwasaki M, et al. Cinacalcet (KRN1493) effectively decreases the serum intact PTH level with favorable control of the serum phosphorus and calcium levels in Japanese dialysis patients. Nephrol Dial Transplant. 2008;23:328-35 (Pubitemid 351767363)
12. Shigematsu T, Akizawa T, Uchida E, Tsukamoto Y, Iwasaki M, Koshikawa S. Long-term cinacalcet HCl treatment improved bone metabolism in Japanese hemodialysis patients with secondary hyperparathyroidism. Am J Nephrol. 2009;29:230-6
13. Urena P, Hruby M, Ferreira A, Ang KS, de Vernejoul MC. Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients. J Am Soc Nephrol. 1996;7:506-12 (Pubitemid 26128321)
14. Hutchison AJ, Whitehouse RW, Boulton HF, Adams JE, Mawer EB, Freemont TJ, et al. Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease. Kidney Int. 1993;44:1071-7 (Pubitemid 23316476)
15. Fukagawa M, Kitaoka M, Inazawa T, Kurokawa K. Imaging of the parathyroid in chronic renal failure: Diagnostic and therapeutic aspects. Curr Opin Nephrol Hypertens. 1997;6:349-55 (Pubitemid 27305408)
16. Nagano N. Pharmacological and clinical properties of calcimimetics: Calcium receptor activators that afford an innovative approach to controlling hyperparathyroidism. Pharmacol Ther. 2006;109:339-65 (Pubitemid 43132817)
17. Lien YH, Silva AL, Whittman D. Effects of cinacalcet on bone mineral density in patients with secondary hyperparathyroidism. Nephrol Dial Transplant. 2005;20:1232-7. (Pubitemid 40862116)